These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 22910085)

  • 21. Left ventricular assist device: can Canada afford this?
    Carrier M
    Can J Cardiol; 2005 Nov; 21(13):1166-8. PubMed ID: 16308591
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term continuous flow left ventricular assist device support and end-organ function: prospects for destination therapy.
    Slaughter MS
    J Card Surg; 2010 Jul; 25(4):490-4. PubMed ID: 20642766
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of the Flowmaker (Jarvik 2000) left ventricular assist device for destination therapy and bridging to transplantation.
    Frazier OH; Shah NA; Myers TJ; Robertson KD; Gregoric ID; Delgado R
    Cardiology; 2004; 101(1-3):111-6. PubMed ID: 14988632
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [End-stage heart failure: role of various circulation assistance techniques].
    Leprince P; Pavie A; Léger P; Bonnet N; Bors V; Levasseur JP; Vaissier E; Gandjbakhch I
    Ann Cardiol Angeiol (Paris); 2000 Feb; 49(1):27-36. PubMed ID: 12555318
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Destination therapy: time for real progress.
    Westaby S
    Nat Clin Pract Cardiovasc Med; 2008 Aug; 5(8):477-83. PubMed ID: 18560406
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy.
    John R; Kamdar F; Liao K; Colvin-Adams M; Boyle A; Joyce L
    Ann Thorac Surg; 2008 Oct; 86(4):1227-34; discussion 1234-5. PubMed ID: 18805167
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical outcome and bridge to transplant rate of left ventricular assist device recipient patients: comparison between continuous-flow and pulsatile-flow devices.
    Garatti A; Bruschi G; Colombo T; Russo C; Lanfranconi M; Milazzo F; Frigerio M; Vitali E
    Eur J Cardiothorac Surg; 2008 Aug; 34(2):275-80; discussion 280. PubMed ID: 18375138
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Perioperative management of ventricular assist devices in children and adolescents.
    Dickerson HA; Chang AC
    Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu; 2006; ():128-39. PubMed ID: 16638558
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Methods of failure and reliability assessment for mechanical heart pumps.
    Patel SM; Allaire PE; Wood HG; Throckmorton AL; Tribble CG; Olsen DB
    Artif Organs; 2005 Jan; 29(1):15-25. PubMed ID: 15644079
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pulsatile vs. continuous flow in ventricular assist device therapy.
    Loor G; Gonzalez-Stawinski G
    Best Pract Res Clin Anaesthesiol; 2012 Jun; 26(2):105-15. PubMed ID: 22910084
    [TBL] [Abstract][Full Text] [Related]  

  • 31. State-of-the-art implantable cardiac assist device therapy for heart failure: bridge to transplant and destination therapy.
    Park SJ; Kushwaha SS; McGregor CG
    Clin Pharmacol Ther; 2012 Jan; 91(1):94-100. PubMed ID: 22113236
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Future devices and directions.
    Clark RE; Zafirelis Z
    Prog Cardiovasc Dis; 2000; 43(1):95-100. PubMed ID: 10935561
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of mechanical circulatory support devices in China.
    Wang W; Zhu DM; Ding WX
    Artif Organs; 2009 Nov; 33(11):1009-14. PubMed ID: 20021474
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Artificial heart].
    Nakatani T
    Kyobu Geka; 2007 May; 60(5):365-71. PubMed ID: 17515079
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Right heart failure and "failure to thrive" after left ventricular assist device: clinical predictors and outcomes.
    Baumwol J; Macdonald PS; Keogh AM; Kotlyar E; Spratt P; Jansz P; Hayward CS
    J Heart Lung Transplant; 2011 Aug; 30(8):888-95. PubMed ID: 21530314
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cardiac prosthesis as an advanced surgical therapy for end-stage cardiac patients: current status and future perspectives.
    Takatani S
    J Med Dent Sci; 2000 Sep; 47(3):151-65. PubMed ID: 12160228
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Destination therapy: current results and future promise.
    Lietz K; Miller LW
    Semin Thorac Cardiovasc Surg; 2008; 20(3):225-33. PubMed ID: 19038733
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Left ventricular device as destination therapy: are we there yet?
    Badiwala MV; Rao V
    Curr Opin Cardiol; 2009 Mar; 24(2):184-9. PubMed ID: 19532106
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Surgical therapy of end-stage heart failure. State of the art 2006].
    Klotz S; Loeher A; Drees G; Scheld HH
    Herz; 2006 Aug; 31(5):445-54. PubMed ID: 16944064
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rotary pumps and diminished pulsatility: do we need a pulse?
    Soucy KG; Koenig SC; Giridharan GA; Sobieski MA; Slaughter MS
    ASAIO J; 2013; 59(4):355-66. PubMed ID: 23820272
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.